TP53 and glioblastoma: Our study provides the first evidence for the role of wtp53-TrxR1axis in regulating response of GSCs to Au and the prospect of implementing a dual-targeting strategy with concomitant synergistic inhibition of Trx/GSH antioxidant systems irrespective of p53 status in GSCs and GBM cell lines in vitro.